Related Experiment Video
Updated: Jan 10, 2026
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Development of Symptomatic Bone Marrow Metastasis After Complete Response to Immunochemotherapy in Squamous Cell Lung
Akari Momose1, Tomonobu Koizumi1,2, Risa Takei1
1Department of Medicine, Nagano Prefectural Kiso Hospital, Nagano, Japan.
Introduction:
Symptomatic bone marrow metastasis in squamous cell lung cancer after achieving a complete response to immunochemotherapy has not been reported previously.
Case Presentation:
A 63-year-old Japanese man was referred to our hospital for further examination of an abnormal chest radiograph. Whole-body computed tomography revealed left hilar swelling and osteolytic lesions. Bronchoscopic examination led to a diagnosis of squamous cell lung carcinoma with multiple bone metastases. He was treated with carboplatin/Nab-paclitaxel and pembrolizumab, and achieved complete response as determined by positron emission tomography with fluorodeoxyglucose-computed tomography. Despite pembrolizumab maintenance therapy for 1 year, thrombocytopenia, anemia, and leukoerythroblastosis occurred. Bone marrow biopsy revealed squamous cell carcinoma cells within fibrotic tissue, confirming the diagnosis of symptomatic bone marrow metastases. The patient died 1 month after this diagnosis.
Conclusion:
Recurrence presenting bone marrow metastasis should be considered in patients with squamous cell lung cancer, even achieving complete response to immunochemotherapy, particularly those with bone metastases.
More Related Videos
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
08:29Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
